Updated Date:
19 Jun 2026
Product Detail:
CABASER Cabergoline 2mg tablet bottle
Shortage Status:
Anticipated
AUST R:
57367
Availability:
Available
Active Ingredient:
cabergoline
Reason:
Manufacturing
Dosage Form:
Tablet,uncoated
Supply Impact Dates
From 20 Jul 2026
To 31 Aug 2026
Management Action:
The sponsor is working to expedite the next shipment. An overseas-registered product containing cabergoline 1mg has been approved for supply under section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals